Diabetic Peripheral Neuropathic Pain Clinical Trial
Official title:
Compare the Effects of Sliding With Tensioner Technique of Neural Mobilization in Diabetic Peripheral Neuropathy Patients
Neurodynamics, i.e., the mobilization of the peripheral nervous system, is a physical approach to the treatment of pain; the method relies on influencing pain physiology via mechanical treatment of neural tissues and the non-neural structures surrounding the nervous system. Neural mobilization (NM) is used to treat various disorders of the nervous system concerning the length and mobility of peripheral nerves, as the nerve mobilizing refers to techniques that help to reestablish motion between a nerve and its surrounding soft tissues, thus to treat the nerves that have become entangled within the soft tissue, as it leads to tension release on a nerve by stretching and pulling one end of the nerve during keeping the other end in a relaxed state.
The neurodynamic technique both sliders and tensioners results in changes of the mechanical or physiological function of nerve tissues along with the interface; restoring pressure gradients, relieving hypoxia and pain resulting in reducing associated symptoms. Through clinical reasoning the nervous system seems to be the logical place for treatment and explanations and previous descriptions of this method have clarified the overall impact on quality of life in diabetic peripheral neuropathy but it doesn't discuss which technique of neural mobilization is more effective and its effects on diabetic peripheral neuropathic population. Within this reasoning it is important to determine which neurodynamic technique is more effective in improving quality of life and reduce pain in patients with diabetic peripheral neuropathy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04094662 -
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
|
Phase 3 | |
Not yet recruiting |
NCT06054087 -
Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy
|
N/A | |
Not yet recruiting |
NCT05292066 -
Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose
|
Early Phase 1 | |
Completed |
NCT04688671 -
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
Recruiting |
NCT06203002 -
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 2 | |
Completed |
NCT05620576 -
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05)
|
Phase 2 | |
Completed |
NCT04146896 -
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
|
Phase 2 | |
Recruiting |
NCT05521737 -
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy
|
N/A | |
Terminated |
NCT04707157 -
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
Terminated |
NCT02156336 -
Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 4 | |
Recruiting |
NCT06122012 -
To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China
|
N/A | |
Recruiting |
NCT06221241 -
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
Completed |
NCT01314222 -
Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 2 | |
Completed |
NCT00829387 -
Cognitive Behavioral Therapy for Diabetic Neuropathic Pain
|
N/A | |
Not yet recruiting |
NCT05766969 -
Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
|
Phase 1/Phase 2 | |
Completed |
NCT03909841 -
Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition
|
||
Completed |
NCT04476108 -
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
Not yet recruiting |
NCT04953221 -
The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain.
|
||
Completed |
NCT05177094 -
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
Completed |
NCT02318706 -
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
|
Phase 3 |